Tech Company Financing Transactions
Amphivena Therapeutics Funding Round
Amphivena Therapeutics, based in San Francisco, secured $14 million in funding from Aeris Capital AG, MPM Capital and private investors.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Tower Pl. 1000
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to eradicate blood cancers with a breakthrough therapy that harnesses the patient's own immune system to destroy tumor cells and precursors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeanmarie Guenot
Chief Scientific Officer
Victoria Smith
VP - Bus. Development
Patrick Chun
VP - Operations
Amy Penticoff
Browse more venture capital transactions:
Prev: 9/30/2013: BioMine venture capital transaction
Next: 9/30/2013: Reality Mobile venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs